4 active not recruiting, 1 completed, 1 recruiting, 1 withdrawn. 7 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Active not recruiting 4, Completed 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Metastatic Primary Peritoneal Carcinoma: new trials by email Literature Review of Metastatic Primary Peritoneal Carcinoma trials Research Report on Metastatic Primary Peritoneal Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers Biopsy Procedure, Biospecimen Collection, Cobimetinib - Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 42 | 2023-09-14 | 2026-10-09 |
| Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel - Advanced Breast Carcinoma, Advanced Endometrial Carcinoma | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 43 | 2022-04-29 | 2026-07-16 |
| Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer Dostarlimab, Niraparib, Biopsy - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 1 | Active not recruiting | University of Washington | 18 | 2021-10-18 | 2026-08-20 |
| Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer Abexinostat Tosylate, Fulvestrant, Palbociclib - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | Phase 1 | Withdrawn | Pamela Munster | 2021-03-31 | 2021-05-18 | |
| Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis Ipilimumab, Laboratory Biomarker Analysis, Nivolumab - Malignant Peritoneal Neoplasm, Malignant Retroperitoneal Neoplasm | Phase 1 | Completed | M.D. Anderson Cancer Center | 26 | 2018-09-21 | 2025-05-22 |
| Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1 Cyclophosphamide, Decitabine, Laboratory Biomarker Analysis - Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Neoplasm | Phase 1 / Phase 2 | Active not recruiting | Roswell Park Cancer Institute | 15 | 2017-07-14 | 2026-07-08 |
| Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Berzosertib, Carboplatin, Gemcitabine Hydrochloride - Metastatic Fallopian Tube Carcinoma, Metastatic Ovarian Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 35 | 2017-05-16 | 2026-07-31 |
Fallopian Tube Neoplasms (7) · Ovarian Neoplasms (6) · Breast Neoplasms (3) · Endometrial Neoplasms (3) · Neoplasm Metastasis (2) · Carcinoma, Endometrioid (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Renal Cell (1) · Carcinosarcoma (1) · Melanoma (1) · Pancreatic Neoplasms (1) · Peritoneal Neoplasms (1) · Sarcoma, Synovial (1) · Uterine Cervical Neoplasms (1)
Adnexal Diseases (7) · Fallopian Tube Diseases (7) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Genital Diseases (7) · Genital Diseases, Female (7) · Genital Neoplasms, Female (7) · Neoplasms (7) · Neoplasms by Site (7) · Urogenital Diseases (7) · Urogenital Neoplasms (7) · Endocrine Gland Neoplasms (6) · Endocrine System Diseases (6) · Gonadal Disorders (6) · Ovarian Diseases (6)
Biopsy (2) · Magnetic Resonance Spectroscopy (2) · 130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · CTLA-4 Antigen (1) · Carboplatin (1) · Cyclophosphamide (1) · Decitabine (1) · Disulfides (1) · Fulvestrant (1) · Gemcitabine (1) · Immunoglobulin G (1) · Injections (1) · Ipilimumab (1) · Leukapheresis (1)
M.D. Anderson Cancer Center (2) · National Cancer Institute (NCI) (2) · Pamela Munster (1) · Roswell Park Cancer Institute (1) · University of Washington (1)
United States (6)
Amir A Jazaeri (1) · Andrea E Wahner Hendrickson (1) · Apostolia M Tsimberidou (1) · Elizabeth M. Swisher (1) · Joyce F Liu (1) · Pamela N Munster, MD (1) · Philip McCarthy, MD (1)
UM1CA186709 (2), N01CM00099 (1), P30CA015083 (1), P30CA016056 (1), R01CA164333 (1), UM1CA186686 (1)